Mersana Therapeutics, Inc.
NaPi2B-TARGETED POLYMER ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF

Last updated:

Abstract:

Disclose herein are dosing regimens for targeted NaPi2b antibody-drug conjugates for treating cancer.

Status:
Application
Type:

Utility

Filling date:

16 Aug 2019

Issue date:

20 Feb 2020